ZYME — Zymeworks Inc. stock price, charts and financials

QT66Zymeworks Inc.

Zymeworks Inc. (NASDAQ: ZYME) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
23.66
+0.12+0.51%
ZYMEQT66Zymeworks Inc.·NASDAQ
23.66+0.51%

Latest SEC Filings

Form category
Filing DateFormDescriptionFilingDocument
Aug 06, 20268-KCurrent report
Aug 06, 202610-QQuarterly report
Jul 06, 20264Statement of changes in beneficial ownership
Jun 29, 20268-KCurrent report
May 15, 20263Initial statement of beneficial ownership
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 20264Statement of changes in beneficial ownership
May 14, 20268-KCurrent report
May 07, 202610-QQuarterly report
May 07, 20268-KCurrent report
Apr 15, 2026SC 13GBeneficial ownership statement (passive)
Apr 10, 20263Initial statement of beneficial ownership
Apr 10, 20263Initial statement of beneficial ownership
Apr 10, 20264Statement of changes in beneficial ownership
Apr 10, 20264Statement of changes in beneficial ownership
Apr 07, 20264Statement of changes in beneficial ownership
Apr 07, 20263Initial statement of beneficial ownership
Apr 01, 20268-KCurrent report
Mar 02, 20268-KCurrent report
Mar 02, 2026S-8Registration of employee benefit securities
Mar 02, 20268-KCurrent report
Mar 02, 202610-KAnnual report
Feb 13, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Feb 12, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Feb 02, 20263Initial statement of beneficial ownership